MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Discover Bernard-Soulier Syndrome Type A1, a rare bleeding disorder, and learn about its diagnosis, genetic testing, personalized treatment strategies, and family planning options.
Discover the role of genetic testing in diagnosing and managing beta-plus-thalassemia, including ethical screening, PGD, and PGT-M for informed treatment and family planning. (159…
Discover the importance of the Junior Blood Group System, its genetic basis, and how genetic testing plays a crucial role in blood transfusion compatibility, disease…
Discover the role of Bone Mineral Density Variation QTL in osteoporosis risk, how genetic testing aids in diagnosis, and its potential benefits for bone health.
Discover the latest findings on genetic testing for breast cancer susceptibility, including gene polymorphisms, early detection, and personalized treatment strategies.
Discover how genetic testing helps diagnose cancer progression, tumor cell motility, and personalized treatment options for various cancer types.
Discover how genetic testing for HLA-A*31:01 and HLA-B*1502 variants can help diagnose carbamazepine hypersensitivity, prevent severe reactions, and improve patient outcomes.
Discover how genetic testing helps diagnose Carbonic Anhydrase I Deficiency, enabling personalized treatment plans, family planning, and advancing research.